Comparison of 3 guideline lipid emulsion regimens for local anesthetic systemic toxicity: an in silico study of bolus duration, total dose, and treatment delay in intravenous bupivacaine overdose

Purpose: Lipid emulsion is the only specific antidote for local anesthetic systemic toxicity, but no dose-finding study has been conducted. We compared 3 published regimens and alternative schedules that deliver the same dose in different ways using a human model of intravenous bupivacaine overdose. Methods: A 14-compartment human bupivacaine model was independently reimplemented without fitted parameters, replacing first-order lipid elimination with a saturable term. Toxicity was modeled as 112.5 mg administered intravenously over 3 minutes. Benefit was defined as the predicted maximum decrease in myocardial bupivacaine within 30 minutes, and harm as the predicted relative lipid load, indexed by peak plasma triglyceride concentration. Neither measure is a validated surrogate. Results: The 3 guidelines specify the same doses but different bolus durations: 1 minute versus 2-3 minutes. At a matched dose of 12 mL/kg, myocardial bupivacaine decreased by 30.5% with the 1-minute bolus and 24.9% with the 2.5-minute bolus, with the same lipid load. The completed American Society of Regional Anesthesia and Pain Medicine regimen (7.64 mL/kg) achieved a 24.6% decrease versus 24.9% with 12 mL/kg; thus, complete regimens differ in schedule as well as dose. Repeating the 1-minute bolus twice, for a total of 4.5 mL/kg, achieved a 31.9% decrease with 62% less emulsion. Start time had the greatest effect: the best regimen achieved a 41.8% decrease when started at the end of the injection, but only 9.6% when started at 10 minutes. Conclusion: In this bupivacaine model, bolus duration distinguished the regimens more than dose did, and delay had a greater effect than either, eliminating most of the benefit without changing the lipid load. Treatment should begin at the first signs of toxicity, and 20% lipid emulsion should be immediately available wherever local anesthetics are used.

Authors

Institutions

Publication Details

Journal
Ewha Medical Journal
Published
2026-10-30
DOI
https://doi.org/10.12771/emj.2026.01648
Primary Topic
Poisoning and overdose treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Comparison of 3 guideline lipid emulsion regimens for local anesthetic systemic toxicity: an in silico study of bolus duration, total dose, and treatment delay in intravenous bupivacaine overdose

Sunho Lim, Sooyoung Cho, Eunbi Cho
1 links
Ewha Medical Journal
Poisoning and overdose treatments
article

Comparison of 3 guideline lipid emulsion regimens for local anesthetic systemic toxicity: an in silico study of bolus duration, total dose, and treatment delay in intravenous bupivacaine overdose

Sunho Lim, Sooyoung Cho, Eunbi Cho
article en

Abstract

Purpose: Lipid emulsion is the only specific antidote for local anesthetic systemic toxicity, but no dose-finding study has been conducted. We compared 3 published regimens and alternative schedules that deliver the same dose in different ways using a human model of intravenous bupivacaine overdose. Methods: A 14-compartment human bupivacaine model was independently reimplemented without fitted parameters, replacing first-order lipid elimination with a saturable term. Toxicity was modeled as 112.5 mg administered intravenously over 3 minutes. Benefit was defined as the predicted maximum decrease in myocardial bupivacaine within 30 minutes, and harm as the predicted relative lipid load, indexed by peak plasma triglyceride concentration. Neither measure is a validated surrogate. Results: The 3 guidelines specify the same doses but different bolus durations: 1 minute versus 2-3 minutes. At a matched dose of 12 mL/kg, myocardial bupivacaine decreased by 30.5% with the 1-minute bolus and 24.9% with the 2.5-minute bolus, with the same lipid load. The completed American Society of Regional Anesthesia and Pain Medicine regimen (7.64 mL/kg) achieved a 24.6% decrease versus 24.9% with 12 mL/kg; thus, complete regimens differ in schedule as well as dose. Repeating the 1-minute bolus twice, for a total of 4.5 mL/kg, achieved a 31.9% decrease with 62% less emulsion. Start time had the greatest effect: the best regimen achieved a 41.8% decrease when started at the end of the injection, but only 9.6% when started at 10 minutes. Conclusion: In this bupivacaine model, bolus duration distinguished the regimens more than dose did, and delay had a greater effect than either, eliminating most of the benefit without changing the lipid load. Treatment should begin at the first signs of toxicity, and 20% lipid emulsion should be immediately available wherever local anesthetics are used.

Ewha Medical Journal
Ewha Womans University (KR), Ewha Womans University Medical Center (KR), Ewha Womans University Mokdong Hospital (KR), Ewha Womans University Seoul Hospital (KR)
Good health and well-being
Openalex Percentile: Top 10%
Poisoning and overdose treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon